Stock CMRX CHIMERIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Chimerix, Inc.

Equities

CMRX

US16934W1062

Market Closed - Nasdaq
Other stock markets
 21:30:00 03/05/2024 BST 		5-day change 1st Jan Change
0.9529 USD +0.28% Intraday chart for Chimerix, Inc. +5.89% -1.00%
05-01 Transcript : Chimerix, Inc., Q1 2024 Earnings Call, May 01, 2024
05-01 Chimerix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Chimerix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Chimerix Appoints Marc D. Kozin to Board of Directors
Chimerix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Chimerix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Chimerix Announces Board Changes
Chimerix Names Michelle LaSpaluto Finance Chief
Chimerix, Inc. Appoints Thomas Riga as Chief Operating and Commercial Officer
Chimerix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to Onc201 Treatment of H3 K27m-Mutant Diffuse Midline Gliomas Published in Cancer Discovery
Chimerix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Chimerix, Inc. Announces CEO Changes, Effective on August 1, 2023
Chimerix, Inc. Announces Executive Changes, Effective on August 1, 2023
Chimerix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Chimerix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Chimerix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
Chimerix, Inc. Announces Successful Launch of ONC201 Phase 3 Action Study
Chimerix Responds to Rubric Capital Management
Chimerix Rejects Shareholder Rubric Capital Management's Call for Liquidation
Rubric Capital Management Sends Letter to Chimerix
Chimerix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CMRX Stock
  4. News Chimerix, Inc.
  5. Other languages